{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:17:15Z","timestamp":1789816635976,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T00:00:00Z","timestamp":1449878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T00:00:00Z","timestamp":1449878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 DK099681"],"award-info":[{"award-number":["K23 DK099681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009560","name":"American Gastroenterological Association","doi-asserted-by":"publisher","award":["Research Scholar Award"],"award-info":[{"award-number":["Research Scholar Award"]}],"id":[{"id":"10.13039\/100009560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40264-015-0372-y","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T08:52:12Z","timestamp":1449910332000},"page":"193-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions"],"prefix":"10.1007","volume":"39","author":[{"given":"Hamed","family":"Khalili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,12]]},"reference":[{"issue":"3","key":"372_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ng.764","volume":"43","author":"CA Anderson","year":"2011","unstructured":"Anderson CA, Boucher G, Lees CW, Franke A, D\u2019Amato M, Taylor KD, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43(3):246\u201352.","journal-title":"Nat Genet."},{"issue":"12","key":"372_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci. Nat Genet. 2010;42(12):1118\u201325.","journal-title":"Nat Genet."},{"issue":"21","key":"372_CR3","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066\u201378.","journal-title":"N Engl J Med."},{"issue":"Suppl 2","key":"372_CR4","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1002\/ibd.20562","volume":"14","author":"CN Williams","year":"2008","unstructured":"Williams CN. Does the incidence of IBD increase when persons move from a low- to a high-risk area? Inflamm Bowel Dis. 2008;14(Suppl 2):S41\u20132.","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"372_CR5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1053\/j.gastro.2012.07.096","volume":"143","author":"H Khalili","year":"2012","unstructured":"Khalili H, Higuchi LM, Ananthakrishnan AN, Manson JE, Feskanich D, Richter JM, et al. Hormone therapy increases risk of ulcerative colitis but not Crohn\u2019s disease. Gastroenterology. 2012;143(5):1199\u2013206.","journal-title":"Gastroenterology."},{"issue":"8","key":"372_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1136\/gutjnl-2012-302362","volume":"62","author":"H Khalili","year":"2013","unstructured":"Khalili H, Higuchi LM, Ananthakrishnan AN, Richter JM, Feskanich D, Fuchs CS, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013;62(8):1153\u20139.","journal-title":"Gut."},{"issue":"1","key":"372_CR7","first-page":"84","volume":"69","author":"RA Berjian","year":"1969","unstructured":"Berjian RA. Regional enteritis, superior mesenteric vein thrombosis, common iliac thromboembolism: possible association with oral contraceptives. J Am Osteopath Assoc. 1969;69(1):84\u20136.","journal-title":"J Am Osteopath Assoc."},{"issue":"20","key":"372_CR8","first-page":"1225","volume":"52","author":"P Delavierre","year":"1976","unstructured":"Delavierre P, Bourdais JP, Hureau J, Vayre P. Intestinal complications during the use of oral contraceptives. Sem Hop Paris. 1976;52(20):1225\u20138.","journal-title":"Sem Hop Paris."},{"issue":"3","key":"372_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF01071971","volume":"18","author":"GK Johnson","year":"1973","unstructured":"Johnson GK, Geenen JE, Hensley GT, Soergel KH. Small intestinal disease, folate deficiency anemia, and oral contraceptive agents. Am J Dig Dis. 1973;18(3):185\u201390.","journal-title":"Am J Dig Dis."},{"issue":"6417","key":"372_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/bmj.288.6417.595","volume":"288","author":"JM Rhodes","year":"1984","unstructured":"Rhodes JM, Cockel R, Allan RN, Hawker PC, Dawson J, Elias E. Colonic Crohn\u2019s disease and use of oral contraception. Br Med J (Clin Res Ed). 1984;288(6417):595\u20136.","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"5","key":"372_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF01071891","volume":"22","author":"S Bonfils","year":"1977","unstructured":"Bonfils S, Hervoir P, Girodet J, Le Quintrec Y, Bader JP, Gastard J. Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis. 1977;22(5):429\u201336.","journal-title":"Am J Dig Dis."},{"key":"372_CR12","doi-asserted-by":"crossref","unstructured":"Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103(9):2394\u2013400.","DOI":"10.1111\/j.1572-0241.2008.02064.x"},{"key":"372_CR13","doi-asserted-by":"crossref","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther. 2005;22(4):309\u201315.","DOI":"10.1111\/j.1365-2036.2005.02564.x"},{"issue":"1","key":"372_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1073\/pnas.0907697107","volume":"107","author":"V Braniste","year":"2010","unstructured":"Braniste V, Jouault A, Gaultier E, Polizzi A, Buisson-Brenac C, Leveque M, et al. Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats. Proc Natl Acad Sci. 2010;107(1):448\u201353.","journal-title":"Proc Natl Acad Sci"},{"key":"372_CR15","doi-asserted-by":"crossref","unstructured":"Looijer-van Langen M, Hotte N, Dieleman LA, Albert E, Mulder C, Madsen KL. Estrogen receptor-beta signaling modulates epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 2011;300(4):G621\u20136.","DOI":"10.1152\/ajpgi.00274.2010"},{"issue":"3","key":"372_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0010-7824(96)00006-6","volume":"53","author":"CM Coenen","year":"1996","unstructured":"Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R. Changes in androgens during treatment with four low-dose contraceptives. Contraception. 1996;53(3):171\u20136.","journal-title":"Contraception."},{"issue":"8","key":"372_CR17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/clinchem\/33.8.1372","volume":"33","author":"TJ Wilke","year":"1987","unstructured":"Wilke TJ, Utley DJ. Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sex-hormone-binding globulin. Clin Chem. 1987;33(8):1372\u20135.","journal-title":"Clin Chem."},{"issue":"3","key":"372_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1095\/biolreprod.107.063545","volume":"78","author":"JA Rettew","year":"2008","unstructured":"Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod. 2008;78(3):432\u20137.","journal-title":"Biol Reprod."},{"issue":"6","key":"372_CR19","first-page":"1378","volume":"21","author":"H Khalili","year":"2015","unstructured":"Khalili H, Ananthakrishnan AN, Konijeti GG, Higuchi LM, Fuchs CS, Richter JM, et al. Endogenous levels of circulating androgens and risk of Crohn\u2019s disease and ulcerative colitis among women: a nested case-control study from the nurses\u2019 health study cohorts. Inflamm Bowel Dis. 2015;21(6):1378\u201385.","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"372_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejogrb.2004.02.001","volume":"117","author":"E Devillard","year":"2004","unstructured":"Devillard E, Burton JP, Hammond JA, Lam D, Reid G. Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis. Eur J Obstet Gynecol Reprod Biol. 2004;117(1):76\u201381.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"2","key":"372_CR21","first-page":"85","volume":"33","author":"CL Galhardo","year":"2006","unstructured":"Galhardo CL, Soares JM Jr, Simoes RS, Haidar MA, Rodrigues de Lima G, Baracat EC. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol. 2006;33(2):85\u20139.","journal-title":"Clin Exp Obstet Gynecol."},{"issue":"9","key":"372_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1139\/w05-070","volume":"51","author":"C Heinemann","year":"2005","unstructured":"Heinemann C, Reid G. Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. Can J Microbiol. 2005;51(9):777\u201381.","journal-title":"Can J Microbiol."},{"issue":"7","key":"372_CR23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1902\/jop.2010.090575","volume":"81","author":"MI Brusca","year":"2010","unstructured":"Brusca MI, Rosa A, Albaina O, Moragues MD, Verdugo F, Ponton J. The impact of oral contraceptives on women\u2019s periodontal health and the subgingival occurrence of aggressive periodontopathogens and Candida species. J Periodontol. 2010;81(7):1010\u20138.","journal-title":"J Periodontol."},{"issue":"6123","key":"372_CR24","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339(6123):1084\u20138.","journal-title":"Science."},{"issue":"1","key":"372_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0016-5085(03)00699-1","volume":"125","author":"OA Hatoum","year":"2003","unstructured":"Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology. 2003;125(1):58\u201369.","journal-title":"Gastroenterology."},{"issue":"4","key":"372_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ibd.21061","volume":"16","author":"CB Ibrahim","year":"2010","unstructured":"Ibrahim CB, Aroniadis OC, Brandt LJ. On the role of ischemia in the pathogenesis of IBD: a review. Inflamm Bowel Dis. 2010;16(4):696\u2013702.","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"372_CR27","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/gut.2009.199679","volume":"60","author":"CW Lees","year":"2011","unstructured":"Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut. 2011;60(12):1739\u201353.","journal-title":"Gut."},{"issue":"10","key":"372_CR28","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004;113(10):1490\u20137.","journal-title":"J Clin Invest."},{"issue":"3","key":"372_CR29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","volume":"157","author":"IJ Fuss","year":"1996","unstructured":"Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn\u2019s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996;157(3):1261\u201370.","journal-title":"J Immunol."},{"issue":"2","key":"372_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129(2):550\u201364.","journal-title":"Gastroenterology."},{"issue":"4","key":"372_CR31","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0016-5085(97)70128-8","volume":"112","author":"G Monteleone","year":"1997","unstructured":"Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, et al. Interleukin 12 is expressed and actively released by Crohn\u2019s disease intestinal lamina propria mononuclear cells. Gastroenterology. 1997;112(4):1169\u201378.","journal-title":"Gastroenterology."},{"key":"372_CR32","doi-asserted-by":"crossref","unstructured":"Cutolo M, Capellino S, Straub RH. Oestrogens in rheumatic diseases: friend or foe? Rheumatology (Oxford). 2008;47(Suppl 3):iii2\u20135.","DOI":"10.1093\/rheumatology\/ken150"},{"key":"372_CR33","doi-asserted-by":"crossref","unstructured":"Gonzalez DA, Diaz BB, Rodriguez Perez Mdel C, Hernandez AG, Chico BN, de Leon AC. Sex hormones and autoimmunity. Immunol Lett. 2010;133(1):6\u201313.","DOI":"10.1016\/j.imlet.2010.07.001"},{"issue":"6","key":"372_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa030808","volume":"349","author":"JE Manson","year":"2003","unstructured":"Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349(6):523\u201334.","journal-title":"N Engl J Med."},{"issue":"9","key":"372_CR35","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/BF01296007","volume":"37","author":"LR Sutherland","year":"1992","unstructured":"Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of oral contraceptive use on reoperation following surgery for Crohn\u2019s disease. Dig Dis Sci. 1992;37(9):1377\u201382.","journal-title":"Dig Dis Sci."},{"issue":"6","key":"372_CR36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0016-5085(98)70419-6","volume":"114","author":"A Timmer","year":"1998","unstructured":"Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn\u2019s disease. The Canadian Mesalamine for Remission of Crohn\u2019s Disease Study Group. Gastroenterology. 1998;114(6):1143\u201350.","journal-title":"Gastroenterology."},{"issue":"2","key":"372_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/gut.45.2.218","volume":"45","author":"J Cosnes","year":"1999","unstructured":"Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of Crohn\u2019s disease: a prospective cohort study. Gut. 1999;45(2):218\u201322.","journal-title":"Gut."},{"issue":"3","key":"372_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.mcna.2015.01.004","volume":"99","author":"G Evans","year":"2015","unstructured":"Evans G, Sutton EL. Oral contraception. Med Clin N Am. 2015;99(3):479\u2013503.","journal-title":"Med Clin N Am."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-015-0372-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0372-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T04:08:20Z","timestamp":1692158900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-015-0372-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["372"],"URL":"https:\/\/doi.org\/10.1007\/s40264-015-0372-y","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,12]]},"assertion":[{"value":"12 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to assist in the preparation of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Khalili is supported by a career development award from the American Gastroenterological Association (AGA) and by the National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK099681).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Grant support"}},{"value":"Dr. Khalili has received consulting fees from Abbvie Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}